Last reviewed · How we verify
Benzimidazole Anthelmintic — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Benzimidazole Anthelmintic (Benzimidazole Anthelmintic) — Centre de Recherche Médicale de Lambaréné.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Benzimidazole Anthelmintic TARGET | Benzimidazole Anthelmintic | Centre de Recherche Médicale de Lambaréné | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Benzimidazole Anthelmintic CI watch — RSS
- Benzimidazole Anthelmintic CI watch — Atom
- Benzimidazole Anthelmintic CI watch — JSON
- Benzimidazole Anthelmintic alone — RSS
Cite this brief
Drug Landscape (2026). Benzimidazole Anthelmintic — Competitive Intelligence Brief. https://druglandscape.com/ci/benzimidazole-anthelmintic. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab